Reducing antibiotic treatment duration for ventilator-associated pneumonia (REGARD-VAP): a trial protocol for a randomised clinical trial

Reducing antibiotic treatment duration for ventilator-associated pneumonia (REGARD-VAP): a trial protocol for a randomised clinical trial

Introduction Ventilator-associated pneumonia (VAP) is the most common nosocomial infection in intensive care units (ICUs). Using short-course antibiotics to treat VAP caused by Gram-negative non-fermenting bacteria has been reported to be associated with excess pneumonia recurrences. The “REducinG A...

Full description

Bibliographic Details
Main Authors: Yin Mo, Direk Limmathurotsakul, Gyan Kayastha, Ben Cooper, Suchart Booraphun, Timothy Eoin West, Graeme MacLaren, Andrew Yunkai Li, Yie Hui Lau, Yin Tze Chew, Ploenchan Chetchotisakd, Paul Anantharajah Tambyah
Format: Article
Language:English
Published: BMJ Publishing Group 2021-05-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/11/5/e050105.full

Internet

https://bmjopen.bmj.com/content/11/5/e050105.full

Similar Items